Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial.
- DOI
- 10.55563/clinexprheumatol/eonoj3
- Published
- 2023 Sep
- Container
- Clinical and experimental rheumatology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.55563/clinexprheumatol/eonoj3,
title = {Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial.},
author = {Moysidou GS and Marotte H and Kossi S and Tubach F and Hajage D and Fautrel B},
year = {2023},
journal = {Clinical and experimental rheumatology},
doi = {10.55563/clinexprheumatol/eonoj3},
url = {https://doi.org/10.55563/clinexprheumatol/eonoj3}
}RIS
TY - JOUR TI - Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial. AU - Moysidou GS AU - Marotte H AU - Kossi S AU - Tubach F AU - Hajage D AU - Fautrel B PY - 2023 JO - Clinical and experimental rheumatology DO - 10.55563/clinexprheumatol/eonoj3 UR - https://doi.org/10.55563/clinexprheumatol/eonoj3 ER -
APA
GS, M., H, M., S, K., F, T., D, H., & B, F. (2023). Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial.. Clinical and experimental rheumatology. https://doi.org/10.55563/clinexprheumatol/eonoj3
Source records
- pubmed · retrieved 2026-09-26T02:43:11.532Z
- europe-pmc · retrieved 2026-09-26T02:43:11.528Z
- hal · retrieved 2026-09-26T02:43:11.555Z